
这个市场不值得进入,结论是否定的。 关键不是预算够不够,而是市场已经进入明显的高竞争、低容错状态:新品牌只有 2 个,但新品牌新品成功率只有 25.00%,全部新上架产品成功率只有 12.50%,近 87.50% 的新产品都没跑出来,已经接近高风险区。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这个市场不适合进入,结论是否定的。 用户预算 500,000 CNY 远高于单个新上架ASIN的早期投入门槛(约 1,176.72 USD,折合约 8,500+ CNY),但市场并不是因为“进得去”就值得进:整体可判定盈利的产品只有 29.63%,新品盈利率只有 12.50%,而新品牌新品的盈利率 25.00%、非盈利率 75.00%,说明新进入者大多数会失败;更关键的是,老品牌新品非盈利率达到 100.00%,说明这个赛道已经被成熟玩家和旧品牌强压,价格和投放都很激烈,不是适合小品牌切入的环境。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,已经接近价格战区,继续做只会更难。 你这条赛道里,新品牌近一年只有1个真正跑通(ZEBORA 的 B0DYHLGJTM),但同时有3个新品牌新品直接失败;按新品口径看,成功率只有25%,而最近几个月新品里失败占比明显更高,4月到11月新增里几乎都是非盈利或未跑通,说明竞争在变差。
证据很清楚:市场里可识别盈利产品只占29.63%,新品盈利率更低;ZEBORA 的成功款 B0DYHLGJTM 唯一可抄,售价17.65美元,前期预算1,176.72美元,前3个月平均卖233件,利润率21.46%,卖点是“透明乳清+电解质+维生素B5/B6”,把蛋白、补水、恢复三个需求绑在一起;但它同品牌另一款 B0FX4FLNV9 直接失败,Protein2o 的新款 B0G2PZPYB5 失败,老品牌新款同样失败,说明不是“随便上个蛋白粉”就能赢。更关键的是,真正赚钱的老品牌样本多是大品牌打法:Protein2o 的 B0DHW4G4H5 月销1000、月营收193.7万美金、利润率10.93%,Ascent 的 B0C792GXBC 月销200、月营收90.36万美金,但这类老品牌的成功靠品牌势能和功能差异,不适合小商家照抄。
你现在的预算500000元人民币是够做单个ASIN的,但不代表能打赢。对大品牌来说,可以参考 Protein2o 的 B0DHW4G4H5 和 Ascent 的 B0C792GXBC,靠品牌力、功能差异和长期投放进场;对小商家来说,唯一像样的成功样本是 ZEBORA 的 B0DYHLGJTM,必须做清爽饮用型、功能叠加、明确区分传统奶昔蛋白,否则就是直接撞进红海。短结论:不要进场;如果硬要做,只能复制 ZEBORA 这种明确差异化路径,但风险仍然很高,而且很可能需要更激进的营销才能站稳。
这不是一个适合新品牌或小商家进入的市场。 新品盈利率只有12.5%,整体可明确判断为低回报环境;更关键的是,真正跑出来的新品几乎都被老品牌和大品牌拿走了,新品牌只有ZEBORA这一家有正向案例,而且样本里还同时出现了亏损新品,说明这个赛道不是靠普通铺货就能赢。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0C792GXBC | Ascent | 2022-02-15 | Yes | $45.18 | 200pcs | $9036.0 | 31.35% | $2832.79 |
![]() | B0DHW4G4H5 | Protein2o | 2024-09-24 | Yes | $19.37 | 1000pcs | $19370.0 | 10.93% | $2117.15 |
![]() | B0CP64J1DQ | Rule 1 Proteins | 2024-07-17 | Yes | $29.27 | 100pcs | $2927.0 | 29.44% | $861.71 |
![]() | B07NMV2FF7 | Z Natural Foods | 2013-03-28 | Yes | $24.99 | 100pcs | $2499.0 | 25.91% | $647.5 |
![]() | B08C7CFQTR | Z Natural Foods | 2020-07-02 | Yes | $24.99 | 50pcs | $1249.5 | 25.53% | $319.0 |
![]() | B01MV3Z05C | BulkSupplements | 2013-08-13 | Yes | $18.07 | 50pcs | $903.5 | 29.83% | $269.52 |
![]() | B0FG924FGR | PEScience | 2025-07-01 | Yes | $14.99 | 100pcs | $1499.0 | 14.49% | $217.21 |
![]() | B0DYHLGJTM | ZEBORA | 2025-10-21 | Yes | $17.65 | 50pcs | $882.5 | 21.46% | $189.39 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0DYHLGJTM | ZEBORA | 2025-10-21 | Yes | $17.65 | 50pcs | $882.5 | 21.46% | $189.39 |
这个市场不适合进入,结论很明确:旧品牌主导、真正新品牌几乎没有可复制的胜利路径,而且新上架产品成功率只有12.50%,已接近高风险区。 更关键的是,旧品牌的新上架是100%不盈利,新品牌里也只有 ZEBORA 这一条真正盈利,说明这不是一个靠普通选品就能赢的市场,而是一个需要强品牌、差异化和较高投入才能勉强切入的市场。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场现在不值得进入:已经明显偏向高竞争、低容错,且新品牌成功率太低。 近端数据只有 2 个新品牌在场,真正新品牌里可复制的成功案例只有 ZEBORA 的 B0DYHLGJTM;而新品牌新上架产品成功率仅 12.50%,失败率 75.00%,这不是适合小商家试错的环境。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 4 |
| 2026 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2025/10 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/12 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |